Karl Goodkin, MD, PhD

Goodkin.Karl-2020.jpgResearch Mentor, Psychiatry

Research Location:
Poynter Hall 42nd and Dewey, SW corner, Fourth floor

Academic Office:
985575 Nebraska Medical Center Omaha, NE 68198-5575

1972 University of Florida Honors Undergraduate Program, Gainesville, Florida.

1973 B.A., Pre-medical and Psychology, Williams College, Williamstown, Massachusetts,

1976 Master's Thesis approved, Washington University, St Louis, Missouri, Clinical Psychology, PhD, Training Program,

1978 MD, University of Miami, Miami, Florida, 

1978 PhD, Clinical Psychology, University of Miami, Coral Gables, Florida,

1982-1983 Intern, Stanford University School of Medicine, Medicine and Psychiatry 

1983-1986 Resident, Department of Psychiatry and Behavioral Sciences, Stanford University 

1986-1987 Research Fellow, Department of Psychiatry and Behavioral Sciences, Stanford University

Biographical Sketch:
Dr. Goodkin has been a member of the Committee on HIV Psychiatry (formerly the Commission on AIDS) of the American Psychiatric Association since 1992 and was a member of the APA’s original Work Group on HIV/AIDS Practice Guidelines -- published in the American Journal of Psychiatry in 2000 and revised in 2006. He was a member of the Algorithms Work Group of the Frascati Conference committee reviewing the American Academy of Neurology’s diagnostic criteria for the HIV-associated neurocognitive disorders (HAND) published in December 2007, in Neurology. Dr. Goodkin was given the Distinguished Service Award in 2004 by the American Society for Microbiology for his services as an Editor of the Journal, Clinical, and Diagnostic Laboratory Immunology. He was the chief editor of the book, The Spectrum of Neuro-AIDS Disorders: Pathophysiology, Diagnosis, and Treatment, published by the American Society for Microbiology (ASM) Press, Inc., in 2009. He is a member of the American College of Psychiatrists and serves on its Scientific Program Committee for the 2016 annual meeting. Dr. Goodkin has been a member of the Neurology Collaborative Science Working Group (formerly the Neurology Sub-Committee) of the AIDS Clinical Trials Group (ACTG) since 1996.  He has served on the Mental Health, AIDS, and Immunology Review Committee of the NIMH and has been a member of review committees for other NIH institutes, including NIA, NINDS, NIDA, NIAID, FIC, NCMHD,  NIDR, and the NEI. He is a founding member of the International Society for Neurovirology and a charter member of the Society on Neuroimmune Pharmacology. Dr. Goodkin served on the consensus panel on the management of older patients with HIV infection published by the American Academy of HIV Medicine in 2011 and revised in 2014. He currently serves on the Neuropsychology Work Group of the Multi-Center AIDS Cohort Study (MACS) and the Neurocognitive Disorders Work Group of the DSM-5. His research interests concern the causes, treatment, and prevention of HIV-1 associated neurocognitive impairment and disorder (HAND), specifically in older persons and in primary Spanish speakers (in the USA, Argentina, Mexico, and Puerto Rico) as well as Portuguese speakers in Brazil and Zulu speakers in South Africa. Dr. Goodkin has conducted clinical trials of HIV-associated neurocognitive impairment, bereavement, and chronic pain (including painful peripheral neuropathy).

Goodkin K, Patten SB: Depressive Symptomatology, Syndromal Depression, and HIV-Associated Neurocognitive Disorder (HAND).  Can J Psychiatry. 2018; 63(5):284-286.

Stoff DM, Goodkin K, Jeste D, Marquine M. Redefining Aging in HIV Infection Using Phenotypes. Curr HIV/AIDS Rep, 2017; 14(5):184-199.

Goodkin K,Miller E, Cox C, Reynolds S, Becker JT, Martin E, Selnes O, Ostrow D, Sacktor N: Effect of Aging on Neurocognitive Function by Stage of HIV Infection: Evidence from the Multi-Center AIDS Cohort Study. Lancet HIV.  2017; 4(9):e411-e422.